APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicotinic Agonists

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nicotinic Agonists Industry Growth and Trends Forecast to 2032

2 January 202693 pages

Choose your research edition.

Industry ResearchNicotinic Agonists Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicotinic Agonists Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Nicotinic Agonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicotinic Agonists Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicotinic Agonists Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Nicotinic Agonists market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nicotinic Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nicotinic Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nicotinic Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nicotinic Agonists include Jiangsu Hansoh Pharmaceutical, Dalian Meilun Biotech Co, BMS, Sumitomo Dainippon Pharma Co, Oyster Point Pharma, Karuna Pharmaceuticals and FORUM Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nicotinic Agonists market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nicotinic Agonists market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nicotinic Agonists market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nicotinic Agonists.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nicotinic Agonists market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nicotinic Agonists Market by Company

Jiangsu Hansoh Pharmaceutical

Dalian Meilun Biotech Co

BMS

Sumitomo Dainippon Pharma Co

Oyster Point Pharma

Karuna Pharmaceuticals

FORUM Pharmaceuticals

Nicotinic Agonists Segment by Type

Epibatidine

Carbachol

Nicotine

Acetylcholine

Others

Nicotinic Agonists Segment by Application

Alzheimer's Disease (AD)

Schizophrenia

Others

Nicotinic Agonists Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinic Agonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicotinic Agonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinic Agonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nicotinic Agonists manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nicotinic Agonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Epibatidine Table 2. Major Company of Carbachol Table 3. Major Company of Nicotine Table 4. Major Company of Acetylcholine Table 5. Major Company of Others Table 6. Global Nicotinic Agonists Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Nicotinic Agonists Sales by Type (2021-2026) & (W Units) Table 8. Global Nicotinic Agonists Sales Market Share in Volume by Type (2021-2026) Table 9. Global Nicotinic Agonists Sales by Type (2021-2026) & (US$ Million) Table 10. Global Nicotinic Agonists Sales Market Share in Value by Type (2021-2026) Table 11. Global Nicotinic Agonists Price by Type (2021-2026) & (US$/Unit) Table 12. Global Nicotinic Agonists Sales by Type (2027-2032) & (W Units) Table 13. Global Nicotinic Agonists Sales Market Share in Volume by Type (2027-2032) Table 14. Global Nicotinic Agonists Sales by Type (2027-2032) & (US$ Million) Table 15. Global Nicotinic Agonists Sales Market Share in Value by Type (2027-2032) Table 16. Global Nicotinic Agonists Price by Type (2027-2032) & (US$/Unit) Table 17. North America Nicotinic Agonists Sales by Type (2021-2026) & (W Units) Table 18. North America Nicotinic Agonists Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Nicotinic Agonists Sales by Type (2021-2026) & (W Units) Table 20. Europe Nicotinic Agonists Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Nicotinic Agonists Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Nicotinic Agonists Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Nicotinic Agonists Sales by Type (2021-2026) & (W Units) Table 24. Latin America Nicotinic Agonists Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Nicotinic Agonists Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Nicotinic Agonists Sales by Type (2021-2026) & (US$ Million) Table 27. Nicotinic Agonists Industry Trends Table 28. Nicotinic Agonists Industry Drivers Table 29. Nicotinic Agonists Industry Opportunities and Challenges Table 30. Nicotinic Agonists Industry Restraints Table 31. Global Nicotinic Agonists Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Nicotinic Agonists Revenue Market Share by Company (2021-2026) Table 33. Global Nicotinic Agonists Sales by Company (2021-2026) & (W Units) Table 34. Global Nicotinic Agonists Sales Share by Company (2021-2026) Table 35. Global Nicotinic Agonists Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Nicotinic Agonists Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Nicotinic Agonists Major Company Production Sites and Headquarters Table 38. Global Nicotinic Agonists Company, Product Type & Application Table 39. Global Nicotinic Agonists Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Nicotinic Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Nicotinic Agonists Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Nicotinic Agonists Sales by Region (2021-2026) & (W Units) Table 44. Global Nicotinic Agonists Sales Market Share in Volume by Region (2021-2026) Table 45. Global Nicotinic Agonists Sales by Region (2021-2026) & (US$ Million) Table 46. Global Nicotinic Agonists Sales Market Share in Value by Region (2021-2026) Table 47. Global Nicotinic Agonists Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Nicotinic Agonists Sales by Region (2027-2032) & (W Units) Table 49. Global Nicotinic Agonists Sales Market Share in Volume by Region (2027-2032) Table 50. Global Nicotinic Agonists Sales by Region (2027-2032) & (US$ Million) Table 51. Global Nicotinic Agonists Sales Market Share in Value by Region (2027-2032) Table 52. Global Nicotinic Agonists Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Nicotinic Agonists Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Nicotinic Agonists Sales by Application (2021-2026) & (W Units) Table 55. Global Nicotinic Agonists Sales Market Share in Volume by Application (2021-2026) Table 56. Global Nicotinic Agonists Sales by Application (2021-2026) & (US$ Million) Table 57. Global Nicotinic Agonists Sales Market Share in Value by Application (2021-2026) Table 58. Global Nicotinic Agonists Price by Application (2021-2026) & (US$/Unit) Table 59. Global Nicotinic Agonists Sales by Application (2027-2032) & (W Units) Table 60. Global Nicotinic Agonists Sales Market Share in Volume by Application (2027-2032) Table 61. Global Nicotinic Agonists Sales by Application (2027-2032) & (US$ Million) Table 62. Global Nicotinic Agonists Sales Market Share in Value by Application (2027-2032) Table 63. Global Nicotinic Agonists Price by Application (2027-2032) & (US$/Unit) Table 64. North America Nicotinic Agonists Sales by Application (2021-2026) & (W Units) Table 65. North America Nicotinic Agonists Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Nicotinic Agonists Sales by Application (2021-2026) & (W Units) Table 67. Europe Nicotinic Agonists Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Nicotinic Agonists Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Nicotinic Agonists Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Nicotinic Agonists Sales by Application (2021-2026) & (W Units) Table 71. Latin America Nicotinic Agonists Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Nicotinic Agonists Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Nicotinic Agonists Sales by Application (2021-2026) & (US$ Million) Table 74. Jiangsu Hansoh Pharmaceutical Company Information Table 75. Jiangsu Hansoh Pharmaceutical Business Overview Table 76. Jiangsu Hansoh Pharmaceutical Nicotinic Agonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Jiangsu Hansoh Pharmaceutical Nicotinic Agonists Product Portfolio Table 78. Jiangsu Hansoh Pharmaceutical Recent Development Table 79. Dalian Meilun Biotech Co Company Information Table 80. Dalian Meilun Biotech Co Business Overview Table 81. Dalian Meilun Biotech Co Nicotinic Agonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Dalian Meilun Biotech Co Nicotinic Agonists Product Portfolio Table 83. Dalian Meilun Biotech Co Recent Development Table 84. BMS Company Information Table 85. BMS Business Overview Table 86. BMS Nicotinic Agonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. BMS Nicotinic Agonists Product Portfolio Table 88. BMS Recent Development Table 89. Sumitomo Dainippon Pharma Co Company Information Table 90. Sumitomo Dainippon Pharma Co Business Overview Table 91. Sumitomo Dainippon Pharma Co Nicotinic Agonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Sumitomo Dainippon Pharma Co Nicotinic Agonists Product Portfolio Table 93. Sumitomo Dainippon Pharma Co Recent Development Table 94. Oyster Point Pharma Company Information Table 95. Oyster Point Pharma Business Overview Table 96. Oyster Point Pharma Nicotinic Agonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Oyster Point Pharma Nicotinic Agonists Product Portfolio Table 98. Oyster Point Pharma Recent Development Table 99. Karuna Pharmaceuticals Company Information Table 100. Karuna Pharmaceuticals Business Overview Table 101. Karuna Pharmaceuticals Nicotinic Agonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Karuna Pharmaceuticals Nicotinic Agonists Product Portfolio Table 103. Karuna Pharmaceuticals Recent Development Table 104. FORUM Pharmaceuticals Company Information Table 105. FORUM Pharmaceuticals Business Overview Table 106. FORUM Pharmaceuticals Nicotinic Agonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. FORUM Pharmaceuticals Nicotinic Agonists Product Portfolio Table 108. FORUM Pharmaceuticals Recent Development Table 109. North America Nicotinic Agonists Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 110. North America Nicotinic Agonists Sales by Country (2021-2026) & (W Units) Table 111. North America Nicotinic Agonists Sales Market Share by Country (2021-2026) Table 112. North America Nicotinic Agonists Sales Forecast by Country (2027-2032) & (W Units) Table 113. North America Nicotinic Agonists Sales Market Share Forecast by Country (2027-2032) Table 114. North America Nicotinic Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. North America Nicotinic Agonists Market Size by Country (2021-2026) & (US$ Million) Table 116. North America Nicotinic Agonists Market Share by Country (2021-2026) Table 117. North America Nicotinic Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. North America Nicotinic Agonists Market Share Forecast by Country (2027-2032) Table 119. Europe Nicotinic Agonists Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 120. Europe Nicotinic Agonists Sales by Country (2021-2026) & (W Units) Table 121. Europe Nicotinic Agonists Sales Market Share by Country (2021-2026) Table 122. Europe Nicotinic Agonists Sales Forecast by Country (2027-2032) & (W Units) Table 123. Europe Nicotinic Agonists Sales Market Share Forecast by Country (2027-2032) Table 124. Europe Nicotinic Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Europe Nicotinic Agonists Market Size by Country (2021-2026) & (US$ Million) Table 126. Europe Nicotinic Agonists Market Share by Country (2021-2026) Table 127. Europe Nicotinic Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Europe Nicotinic Agonists Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific Nicotinic Agonists Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific Nicotinic Agonists Sales by Country (2021-2026) & (W Units) Table 131. Asia-Pacific Nicotinic Agonists Sales Market Share by Country (2021-2026) Table 132. Asia-Pacific Nicotinic Agonists Sales Forecast by Country (2027-2032) & (W Units) Table 133. Asia-Pacific Nicotinic Agonists Sales Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Nicotinic Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Nicotinic Agonists Market Size by Country (2021-2026) & (US$ Million) Table 136. Asia-Pacific Nicotinic Agonists Market Share by Country (2021-2026) Table 137. Asia-Pacific Nicotinic Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Asia-Pacific Nicotinic Agonists Market Share Forecast by Country (2027-2032) Table 139. Latin America Nicotinic Agonists Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 140. Latin America Nicotinic Agonists Sales by Country (2021-2026) & (W Units) Table 141. Latin America Nicotinic Agonists Sales Market Share by Country (2021-2026) Table 142. Latin America Nicotinic Agonists Sales Forecast by Country (2027-2032) & (W Units) Table 143. Latin America Nicotinic Agonists Sales Market Share Forecast by Country (2027-2032) Table 144. Latin America Nicotinic Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Latin America Nicotinic Agonists Market Size by Country (2021-2026) & (US$ Million) Table 146. Latin America Nicotinic Agonists Market Share by Country (2021-2026) Table 147. Latin America Nicotinic Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Latin America Nicotinic Agonists Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa Nicotinic Agonists Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa Nicotinic Agonists Sales by Country (2021-2026) & (W Units) Table 151. Middle East and Africa Nicotinic Agonists Sales Market Share by Country (2021-2026) Table 152. Middle East and Africa Nicotinic Agonists Sales Forecast by Country (2027-2032) & (W Units) Table 153. Middle East and Africa Nicotinic Agonists Sales Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Nicotinic Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Nicotinic Agonists Market Size by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Nicotinic Agonists Market Share by Country (2021-2026) Table 157. Middle East and Africa Nicotinic Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Middle East and Africa Nicotinic Agonists Market Share Forecast by Country (2027-2032) Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Nicotinic Agonists Distributors List Table 162. Nicotinic Agonists Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Nicotinic Agonists Image Figure 2. Global Nicotinic Agonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicotinic Agonists Market Size (2021-2032) & (US$ Million) Figure 4. Global Nicotinic Agonists Sales (2021-2032) & (W Units) Figure 5. Epibatidine Image Figure 6. Global Epibatidine Sales YoY Growth (2021-2032) & (W Units) Figure 7. Carbachol Image Figure 8. Global Carbachol Sales YoY Growth (2021-2032) & (W Units) Figure 9. Nicotine Image Figure 10. Global Nicotine Sales YoY Growth (2021-2032) & (W Units) Figure 11. Acetylcholine Image Figure 12. Global Acetylcholine Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Nicotinic Agonists Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Nicotinic Agonists Market Share by Type 2025 VS 2032 Figure 17. North America Nicotinic Agonists Sales Market Share in Volume by Type in 2025 Figure 18. North America Nicotinic Agonists Sales Market Share in Value by Type in 2025 Figure 19. Europe Nicotinic Agonists Sales Market Share in Volume by Type in 2025 Figure 20. Europe Nicotinic Agonists Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Nicotinic Agonists Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Nicotinic Agonists Sales Market Share in Value by Type in 2025 Figure 23. Latin America Nicotinic Agonists Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Nicotinic Agonists Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Nicotinic Agonists Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Nicotinic Agonists Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Nicotinic Agonists Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Alzheimer's Disease (AD) Image Figure 30. Global Alzheimer's Disease (AD) Sales YoY Growth (2021-2032) & (W Units) Figure 31. Schizophrenia Image Figure 32. Global Schizophrenia Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Nicotinic Agonists Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Nicotinic Agonists Market Share by Application 2025 VS 2032 Figure 37. North America Nicotinic Agonists Sales Market Share in Volume by Application in 2025 Figure 38. North America Nicotinic Agonists Sales Market Share in Value by Application in 2025 Figure 39. Europe Nicotinic Agonists Sales Market Share in Volume by Application in 2025 Figure 40. Europe Nicotinic Agonists Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Nicotinic Agonists Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Nicotinic Agonists Sales Market Share in Value by Application in 2025 Figure 43. Latin America Nicotinic Agonists Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Nicotinic Agonists Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Nicotinic Agonists Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Nicotinic Agonists Sales Market Share in Value by Application in 2025 Figure 47. North America Nicotinic Agonists Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Nicotinic Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Nicotinic Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Nicotinic Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Nicotinic Agonists Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Nicotinic Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Nicotinic Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Nicotinic Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Nicotinic Agonists Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Nicotinic Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Nicotinic Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Nicotinic Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Nicotinic Agonists Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Nicotinic Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Nicotinic Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Nicotinic Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Nicotinic Agonists Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Nicotinic Agonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Nicotinic Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Nicotinic Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Nicotinic Agonists Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Nicotinic Agonists Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Epibatidine
  • Carbachol
  • Nicotine
  • Acetylcholine
  • Others
Applications
  • Alzheimer's Disease (AD)
  • Schizophrenia
  • Others
Companies covered
  • Jiangsu Hansoh Pharmaceutical
  • Dalian Meilun Biotech Co
  • BMS
  • Sumitomo Dainippon Pharma Co
  • Oyster Point Pharma
  • Karuna Pharmaceuticals
  • FORUM Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nicotinic Agonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nicotinic Agonists Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nicotinic Agonists Market by Type
  6. 1.3.1 Epibatidine
  7. 1.3.2 Carbachol
  8. 1.3.3 Nicotine
  9. 1.3.4 Acetylcholine
  10. 1.3.5 Others
  11. 1.4 Global Nicotinic Agonists Market Size by Type
  12. 1.4.1 Global Nicotinic Agonists Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Nicotinic Agonists Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Nicotinic Agonists Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Nicotinic Agonists Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Nicotinic Agonists Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Nicotinic Agonists Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Nicotinic Agonists Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Nicotinic Agonists Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nicotinic Agonists Industry Trends
  2. 2.2 Nicotinic Agonists Industry Drivers
  3. 2.3 Nicotinic Agonists Industry Opportunities and Challenges
  4. 2.4 Nicotinic Agonists Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nicotinic Agonists Revenue (2021-2026)
  2. 3.2 Global Top Players by Nicotinic Agonists Sales (2021-2026)
  3. 3.3 Global Top Players by Nicotinic Agonists Price (2021-2026)
  4. 3.4 Global Nicotinic Agonists Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nicotinic Agonists Major Company Production Sites & Headquarters
  6. 3.6 Global Nicotinic Agonists Company, Product Type & Application
  7. 3.7 Global Nicotinic Agonists Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nicotinic Agonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nicotinic Agonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nicotinic Agonists Tier 1, Tier 2, and Tier 3
4 Nicotinic Agonists Regional Status and Outlook
  1. 4.1 Global Nicotinic Agonists Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nicotinic Agonists Historic Market Size by Region
  3. 4.2.1 Global Nicotinic Agonists Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nicotinic Agonists Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nicotinic Agonists Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nicotinic Agonists Forecasted Market Size by Region
  7. 4.3.1 Global Nicotinic Agonists Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nicotinic Agonists Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nicotinic Agonists Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nicotinic Agonists by Application
  1. 5.1 Nicotinic Agonists Market by Application
  2. 5.1.1 Alzheimer's Disease (AD)
  3. 5.1.2 Schizophrenia
  4. 5.1.3 Others
  5. 5.2 Global Nicotinic Agonists Market Size by Application
  6. 5.2.1 Global Nicotinic Agonists Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Nicotinic Agonists Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Nicotinic Agonists Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Nicotinic Agonists Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Nicotinic Agonists Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Nicotinic Agonists Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Nicotinic Agonists Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Nicotinic Agonists Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Jiangsu Hansoh Pharmaceutical
  2. 6.1.1 Jiangsu Hansoh Pharmaceutical Company Information
  3. 6.1.2 Jiangsu Hansoh Pharmaceutical Business Overview
  4. 6.1.3 Jiangsu Hansoh Pharmaceutical Nicotinic Agonists Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Jiangsu Hansoh Pharmaceutical Nicotinic Agonists Product Portfolio
  6. 6.1.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  7. 6.2 Dalian Meilun Biotech Co
  8. 6.2.1 Dalian Meilun Biotech Co Company Information
  9. 6.2.2 Dalian Meilun Biotech Co Business Overview
  10. 6.2.3 Dalian Meilun Biotech Co Nicotinic Agonists Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Dalian Meilun Biotech Co Nicotinic Agonists Product Portfolio
  12. 6.2.5 Dalian Meilun Biotech Co Recent Developments
  13. 6.3 BMS
  14. 6.3.1 BMS Company Information
  15. 6.3.2 BMS Business Overview
  16. 6.3.3 BMS Nicotinic Agonists Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 BMS Nicotinic Agonists Product Portfolio
  18. 6.3.5 BMS Recent Developments
  19. 6.4 Sumitomo Dainippon Pharma Co
  20. 6.4.1 Sumitomo Dainippon Pharma Co Company Information
  21. 6.4.2 Sumitomo Dainippon Pharma Co Business Overview
  22. 6.4.3 Sumitomo Dainippon Pharma Co Nicotinic Agonists Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sumitomo Dainippon Pharma Co Nicotinic Agonists Product Portfolio
  24. 6.4.5 Sumitomo Dainippon Pharma Co Recent Developments
  25. 6.5 Oyster Point Pharma
  26. 6.5.1 Oyster Point Pharma Company Information
  27. 6.5.2 Oyster Point Pharma Business Overview
  28. 6.5.3 Oyster Point Pharma Nicotinic Agonists Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Oyster Point Pharma Nicotinic Agonists Product Portfolio
  30. 6.5.5 Oyster Point Pharma Recent Developments
  31. 6.6 Karuna Pharmaceuticals
  32. 6.6.1 Karuna Pharmaceuticals Company Information
  33. 6.6.2 Karuna Pharmaceuticals Business Overview
  34. 6.6.3 Karuna Pharmaceuticals Nicotinic Agonists Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Karuna Pharmaceuticals Nicotinic Agonists Product Portfolio
  36. 6.6.5 Karuna Pharmaceuticals Recent Developments
  37. 6.7 FORUM Pharmaceuticals
  38. 6.7.1 FORUM Pharmaceuticals Company Information
  39. 6.7.2 FORUM Pharmaceuticals Business Overview
  40. 6.7.3 FORUM Pharmaceuticals Nicotinic Agonists Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 FORUM Pharmaceuticals Nicotinic Agonists Product Portfolio
  42. 6.7.5 FORUM Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Nicotinic Agonists Sales by Country
  2. 7.1.1 North America Nicotinic Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nicotinic Agonists Sales by Country (2021-2026)
  4. 7.1.3 North America Nicotinic Agonists Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nicotinic Agonists Market Size by Country
  6. 7.2.1 North America Nicotinic Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nicotinic Agonists Market Size by Country (2021-2026)
  8. 7.2.3 North America Nicotinic Agonists Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nicotinic Agonists Sales by Country
  2. 8.1.1 Europe Nicotinic Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nicotinic Agonists Sales by Country (2021-2026)
  4. 8.1.3 Europe Nicotinic Agonists Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nicotinic Agonists Market Size by Country
  6. 8.2.1 Europe Nicotinic Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nicotinic Agonists Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nicotinic Agonists Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nicotinic Agonists Sales by Country
  2. 9.1.1 Asia-Pacific Nicotinic Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nicotinic Agonists Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nicotinic Agonists Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nicotinic Agonists Market Size by Country
  6. 9.2.1 Asia-Pacific Nicotinic Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nicotinic Agonists Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nicotinic Agonists Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nicotinic Agonists Sales by Country
  2. 10.1.1 South America Nicotinic Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nicotinic Agonists Sales by Country (2021-2026)
  4. 10.1.3 South America Nicotinic Agonists Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nicotinic Agonists Market Size by Country
  6. 10.2.1 South America Nicotinic Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nicotinic Agonists Market Size by Country (2021-2026)
  8. 10.2.3 South America Nicotinic Agonists Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nicotinic Agonists Sales by Country
  2. 11.1.1 Middle East and Africa Nicotinic Agonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nicotinic Agonists Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nicotinic Agonists Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nicotinic Agonists Market Size by Country
  6. 11.2.1 Middle East and Africa Nicotinic Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nicotinic Agonists Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nicotinic Agonists Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nicotinic Agonists Value Chain Analysis
  2. 12.1.1 Nicotinic Agonists Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nicotinic Agonists Production Mode & Process
  7. 12.2 Nicotinic Agonists Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nicotinic Agonists Distributors
  10. 12.2.3 Nicotinic Agonists Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst